Compare GenoLogics Life Sciences Software vs Sai Life Sciences
Customers evaluate the quality of GenoLogics Life Sciences Software's products using the following success metrics.
Overview
GenoLogics Life Sciences Software is 23 yrs old and is based in Canada.
GenoLogics is a provider of laboratory information management system (LIMS) software specifically designed for genomics and mass spec research in regulated and unregulated labs. Its Clarity LIMS offers a role-optimized interface and features that make it an invaluable investment for labs that are regulated or CLIA-certified and have NGS technologies. GenoLogics is qualified to meet the current and future lab information management needs of modern genomics and mass spec research laboratories.
Sai Life Sciences is 25 yrs old and is based in India.
Sai Life Sciences offers their clients a wide range of integrated drug discovery, development and formulation services, with core expertise founded in synthetic, medicinal and process chemistry and further augmented by a suite of preclinical support services including DMPK, toxicology and formulation that are continually expanding to meet clients' needs.
Demo Video
Leadership
James DeGreef (Founder)
Jayantt B Manmadkar (Chief Financial Officer)
Investors
Illumina, GrowthWorks
TPG Capital, MPM Capital
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because GenoLogics Life Sciences Software has not claimed their profile.
Work for GenoLogics Life Sciences Software? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for GenoLogics Life Sciences Software?
Claim your profile now.
Information not available because Sai Life Sciences has not claimed their profile.
Work for Sai Life Sciences? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Sai Life Sciences?
Claim your profile now.
Expert Collections
Digital Health
10,563 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.